MOH — authorised 6 August 1959
- Marketing authorisation holder: ACTAVIS LABS UT INC
- Status: likely_approved
MOH authorised Tenuate on 6 August 1959
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 6 August 1959.
ACTAVIS LABS UT INC holds the UAE marketing authorisation.